Evaluation of Cystic Fibrosis Newborn Screening and Follow-Up Process in Georgia (2022–2023)
Cystic fibrosis (CF) is a chronic, autosomal-recessive disorder caused by mutations in the CFTR gene, leading to thickened secretions that affect multiple organ systems. This study examines the effectiveness of Georgia’s national CF screening program, which was initiated in 2012 and includes the mea...
Saved in:
| Main Authors: | Nino Vardosanidze, Nani Kavlashvili, Lali Margvelashvili, Oleg Kvlividze, Mikheil Diakonidze, Saba Iordanishvili, Dodo Agladze |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | International Journal of Neonatal Screening |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2409-515X/11/2/43 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
It Takes All of Us: How the Cystic Fibrosis Foundation Is Supporting States in Advancing Cystic Fibrosis Newborn Screening
by: Mary Dwight, et al.
Published: (2025-05-01) -
Two years of newborn screening for cystic fibrosis in Turkey: Çukurova experience
by: Ayşe Şenay Şaşihüseyinoğlu, et al.
Published: (2019-08-01) -
India: The Last and Best Frontier for Cystic Fibrosis Newborn Screening with Perspectives on Special Challenges
by: Philip M. Farrell, et al.
Published: (2025-04-01) -
Cystic Fibrosis Newborn Screening: A Systematic Review-Driven Consensus Guideline from the United States Cystic Fibrosis Foundation
by: Meghan E. McGarry, et al.
Published: (2025-04-01) -
Unbalanced long-chain fatty acid beta-oxidation in newborns with cystic fibrosis and congenital hypothyroidism
by: Catherina T. Pinnaro, et al.
Published: (2025-03-01)